These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


152 related items for PubMed ID: 6715039

  • 1. Mode of inhibitory action of a bacteriocin produced by Streptococcus mutans C3603.
    Takada K, Ikeda T, Mitsui I, Shiota T.
    Infect Immun; 1984 May; 44(2):370-8. PubMed ID: 6715039
    [Abstract] [Full Text] [Related]

  • 2. Purification and certain properties of a bacteriocin from Streptococcus mutans.
    Ikeda T, Iwanami T, Hirasawa M, Watanabe C, McGhee JR, Shiota T.
    Infect Immun; 1982 Mar; 35(3):861-8. PubMed ID: 7068219
    [Abstract] [Full Text] [Related]

  • 3. Anti-dental caries effect in rats and man of a bacteriocin purified from the oral bacterium Streptococcus mutans C3603.
    Ikeda T, Koulourides T, Kurita T, Housch T, Hirasawa M.
    Arch Oral Biol; 1985 Mar; 30(5):381-4. PubMed ID: 3861142
    [Abstract] [Full Text] [Related]

  • 4. Effect of mutacin administration on Streptococcus mutans-induced dental caries in rats.
    Ooshima T, Yasufuku Y, Izumitani A, Sumi N, Iwanami T.
    Microbiol Immunol; 1985 Mar; 29(12):1163-73. PubMed ID: 3831717
    [Abstract] [Full Text] [Related]

  • 5. Chemical composition of Streptococcus mutans cell walls and their susceptibility to Flavobacterium L-11 enzyme.
    Inoue M, Hamada S, Ooshima T, Kotani S, Kato K.
    Microbiol Immunol; 1979 Mar; 23(5):319-28. PubMed ID: 502897
    [Abstract] [Full Text] [Related]

  • 6. Production and properties of an extracellular bacteriocin from Streptococcus mutans bacteriocidal for group A and other streptococci.
    Paul D, Slade HD.
    Infect Immun; 1975 Dec; 12(6):1375-85. PubMed ID: 1107225
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Isolation and characterization of a Streptococcus mutans bacteriocin inhibitor from Streptococcus pyogenes.
    Perry D, Slade HD.
    Infect Immun; 1978 May; 20(2):578-80. PubMed ID: 352949
    [Abstract] [Full Text] [Related]

  • 11. Purification of bacteriocin LS1 produced by human oral isolate Lactobacillus salivarius BGHO1.
    Busarcevic M, Kojic M, Dalgalarrondo M, Chobert JM, Haertlé T, Topisirovic L.
    Oral Microbiol Immunol; 2008 Jun; 23(3):254-8. PubMed ID: 18402613
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Production of bacteriocins in a liquid medium by Streptococcus mutans.
    Delisle AL.
    Antimicrob Agents Chemother; 1975 Dec; 8(6):707-12. PubMed ID: 1211924
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chemical analyses of membranes isolated from Streptococcus mutans BHT.
    Crowley PJ, Hurst SF, Bleiweis AS.
    J Dent Res; 1984 Dec; 63(12):1343-7. PubMed ID: 6392377
    [Abstract] [Full Text] [Related]

  • 17. Distinct bacteriocin groups correlate with different groups of Streptococcus mutans plasmids.
    Caufield PW, Childers NK, Allen DN, Hansen JB.
    Infect Immun; 1985 Apr; 48(1):51-6. PubMed ID: 2984124
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of leukocyte chemotactic activity of bacteriocin from Streptococcus mutans Rm-10.
    Tsukamoto Y, Fukutani S, Takayama Y, Fukushima H, Sagawa H, Mori M.
    Inflammation; 1990 Oct; 14(5):561-9. PubMed ID: 2249887
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.